How potent is potent before nerve sparing radical retropubic prostatectomy? 1995

P E Zimmern, and J Kaswick, and G E Leach
Department of Urology, Kaiser Sunset Medical Center, Los Angeles, California, USA.

OBJECTIVE We objectively evaluated potency before nerve sparing radical retropubic prostatectomy. METHODS A total of 45 consecutive potent, neurologically normal and sexually active candidates 47 to 70 years old (mean age 62) completed a detailed questionnaire (separate from their partner), and underwent penile biothesiometry, RigiScan* testing for 3 nights, and duplex Doppler scanning of the cavernous arteries before and after prostaglandin E1 injection. RESULTS Of the patients 8 noted moderate and the remainder normal erections on the questionnaire. RigiScan testing and penile biothesiometry correlated poorly with potency status. Duplex scanning demonstrated excellent peak velocities in 93% of the patients. CONCLUSIONS This well studied prospective series underscores the importance of careful objective assessment of potent surgical candidates, and underlines a strong correlation between preoperative potency status and duplex Doppler scanning.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010410 Penile Erection The state of the PENIS when the erectile tissue becomes filled or swollen (tumid) with BLOOD and causes the penis to become rigid and elevated. It is a complex process involving CENTRAL NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEMS; HORMONES; SMOOTH MUSCLES; and vascular functions. Tumescence, Penile,Nocturnal Penile Tumescence,Penile Tumescence,Erection, Penile,Penile Tumescence, Nocturnal,Tumescence, Nocturnal Penile
D010413 Penis The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra. Glans Penis,Penis, Glans
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011468 Prostatectomy Complete or partial surgical removal of the prostate. Three primary approaches are commonly employed: suprapubic - removal through an incision above the pubis and through the urinary bladder; retropubic - as for suprapubic but without entering the urinary bladder; and transurethral (TRANSURETHRAL RESECTION OF PROSTATE). Prostatectomy, Retropubic,Prostatectomy, Suprapubic,Prostatectomies,Prostatectomies, Retropubic,Prostatectomies, Suprapubic,Retropubic Prostatectomies,Retropubic Prostatectomy,Suprapubic Prostatectomies,Suprapubic Prostatectomy
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1

Related Publications

P E Zimmern, and J Kaswick, and G E Leach
February 1985, The Urologic clinics of North America,
P E Zimmern, and J Kaswick, and G E Leach
January 2006, European urology,
P E Zimmern, and J Kaswick, and G E Leach
January 2007, European urology,
P E Zimmern, and J Kaswick, and G E Leach
February 2004, Der Urologe. Ausg. A,
P E Zimmern, and J Kaswick, and G E Leach
September 2005, BJU international,
P E Zimmern, and J Kaswick, and G E Leach
July 1997, The Prostate,
P E Zimmern, and J Kaswick, and G E Leach
January 2005, Prostate cancer and prostatic diseases,
P E Zimmern, and J Kaswick, and G E Leach
September 1988, Urology,
P E Zimmern, and J Kaswick, and G E Leach
September 1999, The Journal of urology,
P E Zimmern, and J Kaswick, and G E Leach
July 1999, BJU international,
Copied contents to your clipboard!